UNIVERSITY OF ANBAR
🇮🇶Iraq
- Country
- 🇮🇶Iraq
- Ownership
- -
- Established
- 1987-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.uoanbar.edu.iq/
Clinical Trials
3
Active:1
Completed:1
Trial Phases
2 Phases
Early Phase 1:2
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Early Phase 1
2 (66.7%)Phase 1
1 (33.3%)Effect of Alum Stone Containing Mucosal Adhesive Patches on Healing of Recurrent Aphthous Stomatitis
Early Phase 1
Completed
- Conditions
- Aphthous Stomatitis, RecurrentAphthous StomatitisAphthous Ulcer
- First Posted Date
- 2025-05-07
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- University Of Anbar
- Target Recruit Count
- 100
- Registration Number
- NCT06960278
- Locations
- 🇮🇶
Iraq, Anbar, Ramadi, 72300, Anbar, Iraq
Taurine Eye Drops May Prevent the Progression of Cataract
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- University Of Anbar
- Target Recruit Count
- 50
- Registration Number
- NCT06639711
- Locations
- 🇮🇶
Al-Nahrain Eye Clinics, Ramadi, Anbar, Iraq
Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease
Early Phase 1
- Conditions
- Clinical Trial
- Interventions
- Drug: Ophtamesone
- First Posted Date
- 2020-09-30
- Last Posted Date
- 2020-09-30
- Lead Sponsor
- University Of Anbar
- Target Recruit Count
- 250
- Registration Number
- NCT04569825
- Locations
- 🇮🇶
Raid Muhmid Al-Ani, Ramadi, Anbar, Iraq
News
No news found